<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02678078</url>
  </required_header>
  <id_info>
    <org_study_id>0671-15-RMB</org_study_id>
    <nct_id>NCT02678078</nct_id>
  </id_info>
  <brief_title>Characterization of Cancer Tissue Using 3D Biosynthetic Material</brief_title>
  <official_title>Characterization of Cancer Tissue Using 3D Biosynthetic Material</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technion, Israel Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Technion, Israel Institute of Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Characterization of Cancer Tissue Using 3D Biosynthetic Materials. Using liver biopsy from
      stage 4 cancer patients, the investigators will evaluate and characterize the metastatic
      cells.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators' biomaterial lab has developed an in vitro diagnostic system in which a
      cancer tumor is placed inside a 3D hydrogel. This material has similar properties to the
      human tissue and can visualize cell migration and proliferation. In this system, the
      investigators have already characterised human metastatic cells obtained from nude mice
      tumors. The diagnostic assay is able to evaluate the reduction in cell growth associated with
      anti-cancer drug therapy. The next step is to test the in vitro diagnostic system using human
      tissue samples from human patients, and to validate the system as a simple and effective a
      priori diagnostic tool for characterizing patient tumours.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>cell growth</measure>
    <time_frame>1 week</time_frame>
    <description>biopsy will be placed inside 3D gel, and growth will be measured over 1 week time.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Analyzing biopsy samples</intervention_name>
    <description>Analyzing biopsy samples that is preformed as part of the patient treatment.</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      we will collect a liver biopsy and blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        every man or women 18 years old or older, with a liver tumor.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  liver tumor

        Exclusion Criteria:

          -  refuse to volunteer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dror seliktar, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Technion, Israel Institute of Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>tarek Saadi, Dr.</last_name>
    <phone>97247772947</phone>
    <email>t_saadi@rambam.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>shlomit harpaz, Msc</last_name>
    <phone>972544565257</phone>
    <email>shlomith@tx.technion.ac.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rambam</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tarek Saadi, Dr.</last_name>
      <phone>972502064575</phone>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2016</study_first_submitted>
  <study_first_submitted_qc>February 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2016</study_first_posted>
  <last_update_submitted>May 5, 2016</last_update_submitted>
  <last_update_submitted_qc>May 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Technion, Israel Institute of Technology</investigator_affiliation>
    <investigator_full_name>Dror Seliktar</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>cancer</keyword>
  <keyword>diagnosis</keyword>
  <keyword>biopsy</keyword>
  <keyword>chemotherapy drugs</keyword>
  <keyword>tumor</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

